Abstract
Understanding pre-exposure prophylaxis (PrEP) discontinuation is key to maximizing its effectiveness at the individual and population levels. Data came from the RADAR cohort study of MSM aged 16–29 years, 2015–2017. Participants included those who reported past 6-month PrEP use and discontinued its use by the interview date. Of the 197 participants who had used PrEP in the past 6 months, 65 discontinued use. Primary reasons for PrEP discontinuation included trouble getting to doctor’s appointments (14, 21.5%) and issues related to insurance coverage or loss (13, 20.0%). Few (21%) who discontinued spoke to their doctor first, which has important implications for future long acting formulations.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 3645-3648 |
| Number of pages | 4 |
| Journal | AIDS and behavior |
| Volume | 22 |
| Issue number | 11 |
| DOIs | |
| State | Published - Nov 1 2018 |
Funding
This work was supported by a Grant from the National Institute on Drug Abuse at the National Institutes of Health (U01DA036939; PI: Mustanski). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute on Drug Abuse or the National Institutes of Health. The sponsor had no involvement in the conduct of the research or the preparation of the article. The authors would like to thank the entire RADAR Research Team, particularly Dr. Thomas Remble and Antonia Clifford for overseeing the project and Daniel T. Ryan for data management. We also thank the RADAR participants for sharing their experiences with us. The authors declare that they have no conflicts of interest.
Keywords
- Discontinuation
- HIV
- PrEP
- YMSM
ASJC Scopus subject areas
- Social Psychology
- Public Health, Environmental and Occupational Health
- Infectious Diseases
